Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection-Reference-Cited by-同舟云学术

Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection

Published:2018-11-20 Issue:2 Volume:49 Page:136-146
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Watanabe Takao¹^ORCID,Tokumoto Yoshio¹,Joko Kouji²^ORCID,Michitaka Kojiro³,Horiike Norio⁴,Tanaka Yoshinori⁵,Tada Fujimasa⁶,Kisaka Yoshiyasu⁷,Nakanishi Seiji⁸,Yamauchi Kazuhiko⁹,Yukimoto Atsushi¹,Hirooka Masashi¹,Abe Masanori¹,Hiasa Yoichi¹^ORCID

Affiliation:

1. Department of Gastroenterology and Metabology; Ehime University Graduate School of Medicine; Toon Japan

2. Center for Liver-Biliary-Pancreatic Diseases; Matsuyama Red Cross Hospital; Matsuyama Japan

3. Department of Gastroenterology; Ehime Prefectural Central Hospital; Matsuyama Japan

4. Department of Gastroenterology; Saiseikai Imabari Hospital; Imabari Japan

5. Department of Gastroenterology; Matsuyama Shimin Hospital; Matsuyama Japan

6. Department of Internal Medicine; Saiseikai Matsuyama Hospital; Matsuyama Japan

7. Department of Gastroenterology; Uwajima City Hospital; Uwajima Japan

8. Department of Gastroenterology; Ehime Prefectural Imabari Hospital; Imabari Japan

9. Department of Gastroenterology; National Hospital Organization Ehime Medical Center; Toon Japan

Funder

JSPS KAKENHI

KAKENHI

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13278/fullpdf

Reference36 articles.

1. Novel therapies for hepatitis C - one pill fits all?;Manns;Nat Rev Drug Discov,2013

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

3. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma;Hoshida;J Hepatol,2014

4. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group;Kasahara;Hepatology,1998

5. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis;Ikeda;Hepatology,1999

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents;Journal of Gastroenterology and Hepatology;2024-04-11

3. The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy;Current Drug Metabolism;2024-02

4. Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong;BMC Gastroenterology;2024-01-25

5. Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study;Hepatology Research;2023-11-28